Navigation Links
Job Cuts from Major Pharmaceutical Firms Results in Tougher Competition, Says Advance Recruitment
Date:3/1/2012

MANCHESTER, England, March 1, 2012 /PRNewswire/ --

Some of the world's largest pharmaceutical firms announced this month they would be cutting thousands of medical sales jobs in order to slash costs and keep investors happy, exposing the worrying dilemma facing the industry.

Biopharmaceutical giants AstraZeneca were the first to announce further job cuts with another 7,300 positions to be axed in 2012. The company has already seen an extraordinary amount of job cuts over recent years with some 12,600 posts removed between 2007-2009 and a further 9,000 last year.

The company blames a mixture of a rise in generic drug firms, pricing pressure and falling returns on drug discovery as the main causes for the increase in job losses in recent years.

The UK currently prescribes some of the cheapest medicines and drugs in Europe according to the Department of Health and the Government has planned to switch to a system of 'value-based pricing' in a bid to promote innovation within the industry.

Another major firm to announce a series of job cuts worldwide was medical devices group Smith & Nephew.

In an effort to save £94.9million, the company said it would have to lose 7% (800 jobs) of its workforce over the course of three years after profits fell 5.3% to £536million in 2011.

However medical sales and marketing recruitment specialists, Advance Recruitment, remain optimistic with regards to new job opportunities within the sector and instead believe the news regarding job cuts has simply caused the competition for new places to increase.

Nick Langley, Managing Director at Advance Recruitment stated, "The announcement of job cuts from a series of major pharmaceutical and medical device firms does not mean the industry is closed to job seekers, but instead is likely to cause the competition for each available placement to rise.

"The medical sales industry remains particularly popular for graduates and job seekers, and medical sales firms will be looking for those who can offer an extensive knowledge in medicine as well as the natural ability to persuade and sell."

Many major firms within the sector also share the same optimism, with GlaxoSmithKline insisting it is in a strong position to reverse falling sales after revealing as many as thirty new drugs likely to be released within the next three years.

The company also stated sales and profit margins will return to growth in 2012 as its efforts to invest heavily in new drugs begin to pay off. As a result the firm are yet to announce any job losses unlike its competitors. Advance Recruitment  specialises in recruiting for healthcare sales,  medical device sales  and marketing jobs for leading healthcare and pharmaceutical companies across the UK. For more information about their current selection of medical sales positions speak to an advisor on 0800-783-0920  or visit  http://www.advancerecruitment.net/.


'/>"/>
SOURCE Advance Recruitment
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012
2. GMH Ventures Acquires Majority Ownership in Dynamic Healthcare Services, Leading Provider of Medical Equipment and Respiratory Therapy Products and Services
3. CME LLC Announces the Launch of the CME Activity Advances in the Management of Major Depressive Disorders
4. Brainlab ExacTrac® System Achieves Major Sales Milestone
5. Neuralstems NSI-189 Trial in Major Depressive Disorder Receives FDA Approval to Advance to Phase Ib
6. Unity Management Group, Inc. Announces Its Initial Sale of the PZ UNO Tablet Press to a Major Pharmaceutical Company for $500,000
7. Ferring Pharmaceuticals To Develop Major Corporate Center in Parsippany, New Jersey
8. Major Israeli Institution Selected to Lead Human Clinical Trials for Revolutionary Alpha Radiation Cancer Therapy
9. Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial
10. Scandal Exposed in Major Study of Autism and Mercury
11. Central Nervous System Disorders Therapeutics Market to 2017 - Multiple Sclerosis, Major Depressive Disorder and Schizophrenia Accounted for Half the Market Value in 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating ... many ways they remain in the eye of the beholder, according to experts who ... of The American Journal of Managed Care. For the full issue, click here ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):